Akebia Therapeutics Inc. (AKBA)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

1.84

0.00%

After-hours Dec 13, 2024, 07:52 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12
Revenue	194.62M	292.60M	213.58M	295.31M	335.00M	207.74M	177.98M	1.53M	-	-	-	-
Cost of Revenue	74.15M	84.80M	153.39M	295.91M	145.34M	7.68M	617.00K	115.78M	96.00K	23.26M	-	-
Gross Profit	120.47M	207.81M	60.18M	-601.00K	189.66M	200.06M	177.37M	-114.25M	-96.00K	-23.26M	-	-
Operating Income	-46.26M	-63.18M	-265.32M	-376.44M	-286.29M	-178.14M	-79.92M	-136.46M	-61.51M	-37.94M	-15.93M	-8.52M
Interest Income	-	15.69M	19.95M	8.92M	2.19M	6.15M	2.80M	901.00K	-	-	-	1.64M
Pretax Income	-51.92M	-92.56M	-282.84M	-383.46M	-286.29M	-171.90M	-76.91M	-135.75M	-60.72M	-37.03M	-13.17M	-8.20M
Net Income	-51.92M	-106.01M	-244.87M	-349.87M	-279.66M	-171.90M	-76.91M	-135.75M	-60.72M	-37.03M	-13.17M	-8.20M
Selling & General & Admin	100.23M	141.87M	174.16M	153.95M	149.46M	87.06M	27.01M	22.21M	18.50M	12.54M	5.15M	2.89M
Research & Development	63.08M	129.11M	147.85M	218.49M	322.97M	291.07M	230.89M	115.78M	43.02M	25.40M	10.78M	5.63M
Other Expenses	3.42M	-12.54M	3.49M	3.41M	3.53M	6.24M	204.00K	-188.00K	287.00K	700.00K	1.05M	1.97M
Operating Expenses	166.73M	270.99M	325.50M	375.84M	475.95M	378.20M	257.90M	138.00M	61.51M	37.94M	15.93M	8.52M
Interest Expense	6.03M	15.69M	19.94M	8.87M	1.40M	6.15M	-	-	510.00K	206.00K	703.57K	-
Selling & Marketing Expenses	100.23M	-3.17M	174.16M	153.95M	149.46M	87.06M	-	-	-	-	-	-
Cost & Expenses	240.88M	355.78M	478.90M	671.75M	621.29M	385.88M	257.90M	138.00M	61.51M	37.94M	15.93M	8.52M
Income Tax	-	13.45M	-37.97M	-33.59M	-6.63M	-28.34M	-2.80M	-901.00K	-510.00K	-206.00K	1.75M	1.60M
Shares Outstanding (Basic)	187.47M	182.78M	165.95M	138.46M	118.40M	116.89M	43.50M	37.72M	26.47M	15.41M	19.27M	10.13M
Shares Outstanding (Diluted)	187.47M	182.78M	165.95M	138.46M	118.40M	116.89M	43.50M	37.72M	26.47M	15.41M	19.27M	10.13M
EPS (Basic)	-0.28	-0.58	-1.48	-2.53	-2.36	-1.47	-1.77	-3.6	-2.29	-2.4	-0.68	-0.81
EPS (Diluted)	-0.28	-0.58	-1.48	-2.53	-2.36	-1.47	-1.77	-3.6	-2.29	-2.4	-0.68	-0.81
EBITDA	-6.87M	-43.26M	-225.96M	-341.00M	-247.64M	-178.09M	-76.06M	-136.16M	-61.42M	-37.89M	-12.46M	-6.55M
Depreciation & Amortization	37.63M	35.28M	36.13M	33.59M	36.42M	2.42M	617.00K	296.00K	96.00K	49.00K	1.28K	39.16K